These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 19787468

  • 21. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.
    Montes de Oca M, Tálamo C, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, Pertuzé J, Moreno D, Halbert RJ, Menezes AM, PLATINO Team.
    Respir Med; 2008 May; 102(5):642-50. PubMed ID: 18314321
    [Abstract] [Full Text] [Related]

  • 22. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M, Mas-Tous C, Renom-Sotorra F, Rubí-Ponseti M, Centeno-Flores MJ, Gorriz-Dolz MT.
    Chron Respir Dis; 2009 May; 6(2):75-80. PubMed ID: 19411567
    [Abstract] [Full Text] [Related]

  • 23. Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease.
    Albers M, Schermer T, Heijdra Y, Molema J, Akkermans R, van Weel C.
    Thorax; 2008 Mar; 63(3):201-7. PubMed ID: 17905823
    [Abstract] [Full Text] [Related]

  • 24. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
    Makris D, Moschandreas J, Damianaki A, Ntaoukakis E, Siafakas NM, Milic Emili J, Tzanakis N.
    Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
    [Abstract] [Full Text] [Related]

  • 25. Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients.
    Chavannes NH, Huibers MJ, Schermer TR, Hendriks A, van Weel C, Wouters EF, van Schayck CP.
    Fam Pract; 2005 Dec; 22(6):604-7. PubMed ID: 16024555
    [Abstract] [Full Text] [Related]

  • 26. Hoover's sign is a predictor of airflow obstruction severity and is not related to hyperinflation in chronic obstructive pulmonary disease.
    Bruyneel M, Jacob V, Sanida C, Ameye L, Sergysels R, Ninane V.
    Eur J Intern Med; 2011 Dec; 22(6):e115-8. PubMed ID: 22075295
    [Abstract] [Full Text] [Related]

  • 27. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.
    Foglio K, Bianchi L, Bruletti G, Porta R, Vitacca M, Balbi B, Ambrosino N.
    Respir Med; 2007 Sep; 101(9):1961-70. PubMed ID: 17531455
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of bronchodilators on dynamic hyperinflation following hyperventilation in patients with COPD.
    Fujimoto K, Yoshiike F, Yasuo M, Kitaguchi Y, Urushihata K, Kubo K, Honda T.
    Respirology; 2007 Jan; 12(1):93-9. PubMed ID: 17207032
    [Abstract] [Full Text] [Related]

  • 30. Six-minute walking distance in women with COPD.
    de Torres JP, Casanova C, Cote CG, López MV, Díaz O, María Marin J, Pinto-Plata V, Montes de Oca M, Aguirre-Jaime A, Celli BR.
    COPD; 2011 Aug; 8(4):300-5. PubMed ID: 21767075
    [Abstract] [Full Text] [Related]

  • 31. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?
    Vestbo J, Lange P.
    Am J Respir Crit Care Med; 2002 Aug 01; 166(3):329-32. PubMed ID: 12153965
    [Abstract] [Full Text] [Related]

  • 32. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM, Tanni SE, Sanchez FF, Pelegrino NR, Lucheta PA, Godoy I.
    Am J Med Sci; 2010 Jan 01; 339(1):10-4. PubMed ID: 19926966
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Long-term follow-up study of moderate chronic obstructive pulmonary disease in elderly patients].
    Xiang PC, Yao Z, Cheng XS, Zhang EM, Zhang X, Song LP, Ju LX, Ding Y, Zhang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep 01; 29(9):583-6. PubMed ID: 17129462
    [Abstract] [Full Text] [Related]

  • 35. The effect of airflow limitation on the cause of death in patients with COPD.
    Alfageme I, Reyes N, Merino M, Reina A, Gallego J, Lima J, Palacios Z.
    Chron Respir Dis; 2010 Aug 01; 7(3):135-45. PubMed ID: 20688891
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-18 production and pulmonary function in COPD.
    Imaoka H, Hoshino T, Takei S, Kinoshita T, Okamoto M, Kawayama T, Kato S, Iwasaki H, Watanabe K, Aizawa H.
    Eur Respir J; 2008 Feb 01; 31(2):287-97. PubMed ID: 17989120
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.